News

Succesful implementation of Quantum Blue­® Adalimumab and Anti-Adalimumab

Learn how Dr. Bernard Royer from the Clinical Pharmacology and Toxicology Service at the Centre Hospitalier Universitaire de Besançon, France, significantly improved turnaround time and streamlined testing processes by adopting the BÜHLMANN therapeutic drug monitoring assays.

Read more

Successful introduction of the fully automated Seegene STARlet-AIOS system with the AllplexTM STI Essential Assay and the AllplexTM GI-EB Screening Assay

Interview with Christophe Zehnder about the successful introduction of the fully automated Seegene STARlet-AIOS system with the AllplexTM STI Essential Assay and the AllplexTM GI-EB Screening Assay

Read more

BÜHLMANN Posters at UEGW 2023

Discover insightful posters from BÜHLMANN focusing on calprotectin assay standardization, presented at the United European Gastroenterology Week 2023!

Read more

The Road towards IVDR with anti-Ganglioside and anti-MAG antibodies

Four posters paving the way towards IVDR certification, explaining the needed steps.

Read more